We further found the mediating role of MIP-1b in the causal association between ANGPTL3 inhibition and CD, with the proportion of mediation effect found to be only 1%, suggesting that ANGPTL3 primarily exerts a direct effect on IBD and CD or that there may be additional unknown mediators that require further exploration. The gene discussed is ANGPTL3; the disease is inflammatory bowel disease.